{
  "docId": "019de514-833c-7520-a4a9-200b68fbb681",
  "docSlug": "d869e39fe11534a9d64784c9e4f475f2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 47 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 47,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-833c-7520-a4a9-200b68fbb681/27",
  "deckHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681",
  "deckJsonHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681.json",
  "deckAnchorHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.035,
        "w": 0.402,
        "x": 0.156,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. See slide 1 for further information on forward-looking statements.\n2. Exclusive licensing agreement with BHVI.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c06907bf-cf6e-438b-a161-67f06557b48d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.439,
        "w": 0.874,
        "x": 0.046,
        "y": 0.248
      },
      "kind": "table",
      "text": "Vision Care\nProduct\nSiHy Daily\nLacelle® colored contact lenses\nBiotrue® Hydration Plus Multi-purpose Solution\nBiotrue® PF Contact Lens Rehydrating Drops (Multidose & Single Dose Use)\nLUMIFY® Line Extensions\nMyopia control contact lens2\nStatus\nLaunched in ~25 countries\nApproved in Japan\nApproved (US FDA, Health Canada, NMPA/ China)\nDesign transfer and Commercialization Readiness stage\nPhase 3 study in progress\nMyopia control contact lens design licensed from BHVI\nUpcoming Milestone\nLaunching SVS into more countries in 2022; Multi-focal and toric launch coming 2023-2024\nNew range of Daily Disposable cosmetic lens launching in Japan in 2022\nU.S. launch ongoing; Canada launched 2H22; China launch expected 1H23\nU.S. FDA submission expected 2022, launch mid-2023\nOne phase 3 clinical study started. Additional studies started in 2H22\nGlobal clinical study to begin in 2023",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82802a96-1c86-49a8-9a94-56442c7c9745",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.039,
        "w": 0.502,
        "x": 0.046,
        "y": 0.084
      },
      "kind": "title",
      "text": "Pipeline and Upcoming Milestones¹",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7263a5fb-5cd3-46cd-9325-439aef8a22e2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}